Arpeggio Biosciences
Arpeggio Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
About Arpeggio Biosciences
Based in the United States, Arpeggio Biosciences is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Arpeggio Biosciences develops a drug-discovery technology that reads cell transcriptional changes to screen the activity of tens of thousands of compounds across diseased and healthy cells. The platform has established strategic partnerships with major pharmaceutical companies including Pfizer, Janssen, Genentech and Novartis.
Explore Arpeggio Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.